Showing 1,301 - 1,320 results of 3,171 for search '(( significant decrease decrease ) OR ( significant ((all decrease) OR (a decrease)) ))~', query time: 0.67s Refine Results
  1. 1301

    Schematic diagram of the study design. by Yan Zhu (112437)

    Published 2025
    “…<div><p>Background</p><p>Type 2 diabetes mellitus (T2DM) is associated with cognitive dysfunction, which significantly impacts the quality of life. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown potential neuroprotective effects. …”
  2. 1302

    Supplementary file 1_Therapeutic effects of Balanites aegyptiaca DEL extract on diabetes mellitus: a systematic review.pdf by Olubukola Adebisi Odeniran (22162777)

    Published 2025
    “…All the studies were appraised for blood glucose levels, and a reduction in blood glucose was reported in all in vivo studies, regardless of the plant part used. …”
  3. 1303

    Supplementary file 2_Therapeutic effects of Balanites aegyptiaca DEL extract on diabetes mellitus: a systematic review.pdf by Olubukola Adebisi Odeniran (22162777)

    Published 2025
    “…All the studies were appraised for blood glucose levels, and a reduction in blood glucose was reported in all in vivo studies, regardless of the plant part used. …”
  4. 1304

    IntegraBrain: A multi-modal neural interface for the detection and suppression of focal epilepsy by Spencer Moore (8440863)

    Published 2025
    “…Comparison of nominal seizure recordings to those during active cooling indicate successful seizure suppression with seizure activity suppression increasing as cooling temperature decreases. A ~67% reduction in broadband seizure magnitude (0-30Hz) was recorded when cooling to 18°C.…”
  5. 1305

    Image 2_Plasma fibrinogen level and acute aortic dissection prognosis—insights from a two-center cohort study.pdf by Jiaxin Xiao (4423546)

    Published 2025
    “…</p>Conclusions<p>Low PFL is a risk factor for short and long-term all-cause mortality in patients with type A AAD and short-term all-cause mortality in patients with type B AAD.…”
  6. 1306

    Table 1_Plasma fibrinogen level and acute aortic dissection prognosis—insights from a two-center cohort study.pdf by Jiaxin Xiao (4423546)

    Published 2025
    “…</p>Conclusions<p>Low PFL is a risk factor for short and long-term all-cause mortality in patients with type A AAD and short-term all-cause mortality in patients with type B AAD.…”
  7. 1307

    Image 1_Plasma fibrinogen level and acute aortic dissection prognosis—insights from a two-center cohort study.pdf by Jiaxin Xiao (4423546)

    Published 2025
    “…</p>Conclusions<p>Low PFL is a risk factor for short and long-term all-cause mortality in patients with type A AAD and short-term all-cause mortality in patients with type B AAD.…”
  8. 1308

    Image 4_Plasma fibrinogen level and acute aortic dissection prognosis—insights from a two-center cohort study.pdf by Jiaxin Xiao (4423546)

    Published 2025
    “…</p>Conclusions<p>Low PFL is a risk factor for short and long-term all-cause mortality in patients with type A AAD and short-term all-cause mortality in patients with type B AAD.…”
  9. 1309

    Table 2_Plasma fibrinogen level and acute aortic dissection prognosis—insights from a two-center cohort study.pdf by Jiaxin Xiao (4423546)

    Published 2025
    “…</p>Conclusions<p>Low PFL is a risk factor for short and long-term all-cause mortality in patients with type A AAD and short-term all-cause mortality in patients with type B AAD.…”
  10. 1310

    Image 3_Plasma fibrinogen level and acute aortic dissection prognosis—insights from a two-center cohort study.pdf by Jiaxin Xiao (4423546)

    Published 2025
    “…</p>Conclusions<p>Low PFL is a risk factor for short and long-term all-cause mortality in patients with type A AAD and short-term all-cause mortality in patients with type B AAD.…”
  11. 1311
  12. 1312
  13. 1313

    Table 1_Survival assessment in extremely preterm neonates in a middle-income setting.docx by Maria J. Rodriguez-Sibaja (17456689)

    Published 2025
    “…Overall mortality decreased with increasing gestational age, from 100% (22/22) at <24.0 weeks of gestation to 87% (14/16), 42% (16/38), and 21% (11/52) at a gestational age of 25, 26, and 27 weeks, respectively. …”
  14. 1314

    Table 2_Survival assessment in extremely preterm neonates in a middle-income setting.docx by Maria J. Rodriguez-Sibaja (17456689)

    Published 2025
    “…Overall mortality decreased with increasing gestational age, from 100% (22/22) at <24.0 weeks of gestation to 87% (14/16), 42% (16/38), and 21% (11/52) at a gestational age of 25, 26, and 27 weeks, respectively. …”
  15. 1315

    Polygenic adaptation analysis results for the pairwise and multi-population tests for polygenic adaptation (see Methods). by Olivia A. Gray (20700832)

    Published 2025
    “…The SNP no. column shows how many SNPS are included in the test at this significance threshold. Significant <i>p</i>-values are highlighted in green (figures for all significant Multi-population tests in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1011570#pgen.1011570.s006" target="_blank">S6 Fig</a>). …”
  16. 1316

    Table 1_The efficacy of infliximab combined with partial enteral nutrition in the treatment of Crohn’s disease: a cohort study.docx by Chen Huang (202847)

    Published 2025
    “…</p>Results<p>Among the 176 included patients, 99 (56%) were in the IFX monotherapy group, and 77 (44%) were in the IFX + PEN group. A significantly higher proportion of patients in the IFX + PEN group achieved clinical response (defined as a CDAI decrease ≥70 points) compared to those in the IFX group at 14 weeks (87.01% vs. 74.75%, p = 0.043), as well as a higher proportion achieving endoscopic remission at 54 weeks (84.42% vs. 65.66%, p = 0.005). …”
  17. 1317

    Table 1_The effects of trace element supplementation on glycolipid metabolism in PCOS: a systematic review and meta-analysis.docx by Liuzhen Yang (20449762)

    Published 2025
    “…The results showed a significant decrease in fasting blood glucose levels (SMD = −0.79, 95% CI: −1.11 to −0.46). …”
  18. 1318

    Table 1_Association of the ROX index with mortality in sepsis patients: a retrospective study.docx by Jiali Wu (701228)

    Published 2025
    “…Restricted cubic spline analysis revealed a nonlinear “L”-shaped association, with the 28-day mortality risk decreasing until reaching a plateau at a ROX index of approximately 10.50. …”
  19. 1319

    Data Sheet 1_Efficacy and safety of reduning injection for severe pneumonia: a systematic review and meta-analysis.docx by Yan Wang (15435)

    Published 2025
    “…Objectives<p>Reduning (RDN) injection is a traditional Chinese medicine (TCM) extract injection commonly used as an adjunct therapy for severe pneumonia (SP) in clinical practice in China; however, further validation is required. …”
  20. 1320

    Supplementary Material for: A Randomized Controlled Crossover Trial to Determine the Effects of Three Nostril Regulated Breathing Practices on Attention and Mood by figshare admin karger (2628495)

    Published 2025
    “…A significant main effect of states was observed followed by significant post-hoc pair wise comparison in right NDR for (i) pleasant mood after SAV, CAV, AV and QS, (ii) positive mood after SAV and AV, and (iii) global vigor after SAV, CAV, AV and QS, and (iv) a decrease in negative mood after CAV and AV. …”